Amwell (NYSE: AMWL) reported Q4 EPS of ($0.17), $0.03 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $70.7 million versus the consensus estimate of $70.17 million.

For earnings history and earnings-related data on Amwell (AMWL) click here.